-+ 0.00%
-+ 0.00%
-+ 0.00%

OMNIOSE: ACQUISITION BRINGS OMNIOSE'S PROPRIETARY BIOCONJUGATION PLATFORM AND EXPERTISE INTO ASTRAZENECA

Reuters·11/10/2026 13:02:38